Evidence-based strategies for treating youth at familial risk for developing bipolar disorder
The pros and cons of various pharmacotherapeutic options in depression, schizophrenia, bipolar disorders, ADHD and child and adolescent psychiatric disorders
Evidence base involving the short- and long-term efficacy versus safety risks of antidepressants in patients with bipolar depression
Relative outcomes after augmentation versus switching strategies in treatment-resistant depression
Data relevant to the therapeutic profile of lithium vs. anticonvulsants in the treatment of bipolar disorder
Differentiate bipolar disorder from ADHD even when they co-exist
